Newbridge Financial Services Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
Other funds holding NBSE
Newbridge Financial Services Group's NBSE Position: Q2 2024 in Review
Newbridge Financial Services Group sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2024, closing a stake of 12 shares — an estimated $5 sold.
Newbridge Financial Services Group first reported a position in NBSE in Q3 2020 and held it in 15 quarters. The position peaked at $2K in Q1 2021. 3 funds tracked by Wall St. Rank hold NBSE as of Q2 2024.
- Newbridge Financial Services Group reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Newbridge Financial Services Group sold 12 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $5.
- Newbridge Financial Services Group first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
- Newbridge Financial Services Group's NeuBase Therapeutics, Inc. Common Stock position peaked at $2K in Q1 2021.
- 3 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.